![Ardelyx Inc](/common/images/company/N_ARDX.png)
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is ten... Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0722 | 1.26889279438 | 5.69 | 5.85 | 5.37 | 2720157 | 5.55083792 | CS |
4 | 0.5622 | 10.8115384615 | 5.2 | 5.85 | 4.85 | 3452039 | 5.36332059 | CS |
12 | 0.6622 | 12.9843137255 | 5.1 | 6.07 | 4.32 | 4098516 | 5.25667024 | CS |
26 | -0.0878 | -1.50085470085 | 5.85 | 7.18 | 4.32 | 3846294 | 5.52849242 | CS |
52 | -3.2778 | -36.2588495575 | 9.04 | 9.83 | 4.32 | 4523055 | 6.50018773 | CS |
156 | 5.0771 | 741.074295723 | 0.6851 | 10.13 | 0.4902 | 5400377 | 4.2019245 | CS |
260 | -1.8778 | -24.5785340314 | 7.64 | 10.13 | 0.4902 | 4961250 | 3.5888078 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales